Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Liminatus Pharma Inc. (LIMN) Return on Tangible Equity data is not available.
| Income Statement Financials | |
-- |
|
$-0.00M |
|
-- |
|
-- |
|
$-0.00M |
|
$0.00M |
|
-- |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
0.00M |
|
0.00M |
|
$-2.55 |
|
$-2.55 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$-0.00M |
|
$-0.00M |
|
$-0.00M |
|
0.00M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|